全文获取类型
收费全文 | 260篇 |
免费 | 16篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 2篇 |
妇产科学 | 5篇 |
基础医学 | 16篇 |
临床医学 | 29篇 |
内科学 | 87篇 |
神经病学 | 11篇 |
特种医学 | 4篇 |
外科学 | 32篇 |
预防医学 | 15篇 |
眼科学 | 11篇 |
药学 | 14篇 |
中国医学 | 3篇 |
肿瘤学 | 44篇 |
出版年
2023年 | 2篇 |
2022年 | 1篇 |
2021年 | 7篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 7篇 |
2017年 | 14篇 |
2016年 | 10篇 |
2015年 | 10篇 |
2014年 | 13篇 |
2013年 | 10篇 |
2012年 | 18篇 |
2011年 | 15篇 |
2010年 | 10篇 |
2009年 | 6篇 |
2008年 | 22篇 |
2007年 | 21篇 |
2006年 | 25篇 |
2005年 | 9篇 |
2004年 | 10篇 |
2003年 | 11篇 |
2002年 | 6篇 |
2001年 | 2篇 |
2000年 | 7篇 |
1999年 | 3篇 |
1998年 | 2篇 |
1997年 | 1篇 |
1996年 | 3篇 |
1994年 | 1篇 |
1993年 | 3篇 |
1992年 | 5篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1988年 | 2篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1983年 | 3篇 |
1981年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有276条查询结果,搜索用时 15 毫秒
51.
6-(Methylsulfinyl)hexyl isothiocyanate (6-MITC) is an active ingredient of Wasabi (Wasabia japonica (Miq.) Matsumura), which is a very popular pungent spice in Japan. To clarify the cellular signaling mechanism underlying the anti-inflammatory action of 6-MITC, we investigated the effects of 6-MITC on the expression of inducible nitric oxide synthase (iNOS) in lipopolysaccharide (LPS)-activated murine macrophage RAW264 cells. 6-MITC showed a dose-dependent inhibition of LPS-induced nitric oxide (NO), iNOS mRNA and protein. LPS caused the c-Jun phosphorylation (a major component of AP-1) and IkappaB-alpha degradation. 6-MITC suppressed LPS-induced c-Jun phosphorylation, but did not inhibit IkappaB-alpha degradation. Cellular signaling analysis using MAPK-(U0126 for MEK1/2, SB203580 for p38 kinase and SP600125 for JNK) and Jak2-specific (AG490) inhibitors demonstrated that LPS stimulated iNOS expression via activating Jak2-mediated JNK, but not ERK and p38, pathway. 6-MITC suppressed iNOS expression through the inhibition of Jak2-mediated JNK signaling cascade with the attendant to AP-1 activation. In addition, the structure-activity study revealed that the inhibitory potency of methylsulfinyl isothiocyanates (MITCs) depended on the methyl chain length. These findings provide the molecular basis for the first time that 6-MITC is an effective agent to attenuate iNOS production. 相似文献
52.
Kurosawa S Yamaguchi T Miyawaki S Uchida N Kanamori H Usuki K Yamashita T Watanabe M Yakushiji K Yano S Nawa Y Taguchi J Takeuchi J Tomiyama J Nakamura Y Miura I Kanda Y Takaue Y Fukuda T 《Blood》2011,117(7):2113-2120
Various prospective trials have been performed to assess the roles of allogeneic hematopoietic cell transplantation (allo-HCT) and chemotherapy in patients with acute myeloid leukemia (AML) in first complete remission (CR1). However, the results have not always been consistent, and there has been a limited evaluation of quality of life (QOL) in these postremission strategies. We performed a Markov decision analysis that enabled us to compare survival outcomes with a QOL evaluation using a database of 2029 adult AML patients who achieved CR1. The Markov decision model compared 2 strategies: allo-HCT or chemotherapy in CR1. Patients who had intermediate- or unfavorable-risk AML had a longer life expectancy when they received allo-HCT in CR1 than patients treated with chemotherapy alone. Likewise, patients who had a suitable related donor who received allo-HCT in CR1 had a longer life expectancy. The life expectancy was shortened to a greater degree by adjustment for QOL in the allo-HCT group. Nevertheless, QOL-adjusted life expectancies in most of the subgroups remained longer in the allo-HCT group than in the chemotherapy group. Our results showed that older patients with a related donor and younger patients with unfavorable cytogenetics benefited the most from allo-HCT in CR1. 相似文献
53.
Watanabe N Noh JY Narimatsu H Takeuchi K Yamaguchi T Kameyama K Kobayashi K Kami M Kubo A Kunii Y Shimizu T Mukasa K Otsuka F Miyara A Minagawa A Ito K Ito K 《British journal of haematology》2011,153(2):236-243
There are few large‐scale reports of primary thyroid lymphoma (PTL). This study clinically and pathologically reviewed 171 patients with PTL and 24 553 patients with Hashimoto’s disease at Ito Hospital between January 1990 and December 2004, to investigate the clinical features and the treatment outcomes of PTL. The median age of the patients with PTL was 67 years (range, 27–90 years). The pathological diagnosis of PTL patients included diffuse large B‐cell lymphoma (DLBCL) (n = 74), DLBCL with mucosa‐associated lymphoid tissue (MALT) lymphoma (n = 13), MALT lymphoma (n = 80) and others (n = 4). Of the 167 patients with B‐cell lymphoma, treatment included combined modality therapy (CMT) (n = 95), radiation therapy (RT) alone (n = 60) and chemotherapy alone (n = 6). Information on treatment was not available in six patients. Information on treatment response was available in 154 patients; 149 patients (97%) responded to treatment. According to the institutional treatment strategy of Ito Hospital, 45 of 54 patients with stage IE disease received RT alone, and 87 of 113 stage IIE patients received CMT. The 5‐year overall survival rate was 85% (95% confidence interval, 79–91%). This study demonstrated that PTL showed good response to radiotherapy and chemotherapy and had a favourable prognosis. 相似文献
54.
Hiromichi Maeda Isao Nishimori Takehiro Okabayashi Takuhiro Kohsaki Taro Shuin Michiya Kobayashi Saburo Onishi Kazuhiro Hanazaki 《Clinical journal of gastroenterology》2009,2(3):222-225
Von Hippel–Lindau disease (VHLD) is an autosomal dominant familial syndrome associated with multiple neoplasms. Medical management
of pancreatic lesions is still controversial, especially for pancreatic neuroendocrine tumors (NET). We report an experience
of total pancreatectomy for multiple pancreatic neuroendocrine tumors in a VHLD patient, and discuss the indication of surgical
treatment. The patient was a 33-year-old Japanese female with a medical history of VHLD-associated tumors. At 27 years of
age, abdominal computed tomography revealed a number of strongly enhanced round tumors throughout the pancreas. She underwent
total pancreatectomy with portal vein resection because of back pain and an increase of tumor size. Pathological examination
reconfirmed the diagnosis of multiple pancreatic NET invading the portal vein. She has been well with intensive insulin therapy
and has shown no recurrence of NET for more than one year. This is a rare case of total pancreatectomy with portal vein resection
for treatment of pancreatic NET in a VHLD patient. Total pancreatectomy is a viable option for treatment of multi-centric
or extensive pancreatic NET because of a favorable prognosis of NET after radical surgical treatment. 相似文献
55.
Kitajima Y Endo T Nagasawa K Manase K Honnma H Baba T Hayashi T Chiba H Sawada N Saito T 《Endocrinology》2006,147(2):694-699
We investigated the mechanism by which a GnRH agonist (GnRHa) affects ovarian vascularity, vascular permeability, and expression of the tight junction protein claudin-5 in a rat model of ovarian hyperstimulation syndrome (OHSS). Hyperstimulated rats received excessive doses of pregnant mare serum gonadotropin (PMSG; 50 IU/d) for 4 consecutive days, from d 25 to 28 of life, followed by 25 IU human chorionic gonadotropin (hCG) on d 29. Control rats received 10 IU PMSG on d 27 of life, followed by 10 IU hCG on d 29. GnRHa (leuprolide 100 microg/kg.d) was administered to some hyperstimulated rats either on d 29 and 30 (short-term GnRHa treatment) or from d 25 to 30 (long-term GnRHa treatment). Ovarian vascular density (vessels per 10 mm(2)) and vessel endothelial area (percent) were assessed by immunohistochemical analysis of the distribution of von Willebrand factor, whereas vascular permeability was evaluated based on leakage of Evans blue. High doses of PMSG and hCG significantly increased ovarian weight, vascular permeability, vascular density, and the vessel endothelial area and significantly reduced expression of claudin-5 protein and mRNA. All of these effects were significantly and dose-dependently inhibited by administration of GnRHa. This suggests that reduced expression of claudin-5 plays a crucial role in the increased ovarian vascular permeability seen in OHSS and that its expression can be modulated by GnRHa treatment. Indeed, preventing redistribution of tight junction proteins in endothelial cells and the resultant loss of endothelial barrier architecture might be the key to protecting patients against massive extravascular fluid accumulation in cases of OHSS. 相似文献
56.
Yoshida T Yazaki M Gono T Tazawa K Morita H Matsuda M Funakoshi K Yuki N Ikeda S 《Journal of the neurological sciences》2006,244(1-2):167-171
We report a patient with severe cranial polyneuropathy as well as sensory limb neuropathy. Biclonal serum IgM-kappa/IgM-lambda gammopathy was found and serum anti-myelin-associated glycoprotein (MAG)/sulfoglucuronyl paragloboside (SGPG) IgM antibody was also detected. Immunofluorescence analysis of a sural nerve biopsy specimen revealed binding of IgM and lambda-light chain on myelin sheaths. No amyloid deposition was detected in biopsied tissues except for the hard palate, suggesting that the amyloidosis was of the localized type and had no relation to the pathogenesis of cranial neuropathy. Our observations indicate that the anti-MAG/SGPG IgM antibody may be responsible for this patient's cranial polyneuropathy, which is a rare manifestation in anti-MAG/SGPG-associated neuropathy. 相似文献
57.
Masahiro Jinzaki Masaharu Hirano Kazuhiro Hara Takahiko Suzuki Akira Yamashina Yuji Ikari Misako Iino Takuhiro Yamaguchi Sachio Kuribayashi 《The international journal of cardiovascular imaging》2013,29(1):7-20
The purpose of this study was to compare the safety and efficacy of the short-acting β1-receptor blocker, landiolol hydrochloride (0.06 and 0.125-mg/kg), to placebo during coronary computed tomography angiography (CTA) in a phase 2 dose-finding study. A total of 183 patients suspected of having ischemic cardiac disease and scheduled to undergo an invasive coronary angiography were randomized to groups treated with landiolol hydrochloride (0.06 or 0.125-mg/kg) or placebo. The heart rate, safety, and the performance of coronary diagnosis using landiolol hydrochloride were evaluated in a multicenter, double-blind, randomized, parallel study. The patients’ heart rates during the coronary CTA were 67.6 ± 8.7 and 62.6 ± 7.8 beats/min in the 0.06 and 0.125-mg/kg landiolol hydrochloride groups, respectively, both of which were significantly lower than the heat rate of 73.7 ± 11.8 beats/min in the placebo group (P = 0.003 and P < 0.001, respectively). No adverse events or reactions occurred at an incidence of 5 % or greater, confirming the safety of landiolol hydrochloride. The proportion of correctly classified patients was significantly higher in the 0.125-mg/kg landiolol hydrochloride group than in the placebo group (73.6 vs. 50.0 %). Landiolol hydrochloride at doses of 0.06 and 0.125-mg/kg significantly decreased the heart rate compared with a placebo. The present findings suggest that landiolol hydrochloride is safe and useful at a dose of 0.125-mg/kg to improve coronary diagnostic performance during coronary CTA. 相似文献
58.
Ehara S Shirai N Okuyama T Matsumoto K Matsumura Y Yoshiyama M 《Heart and vessels》2011,26(5):487-494
The identification and intervention of factors associated with a coronary artery calcification (CAC) score of zero, suggesting
the absence of significant coronary artery disease (CAD) with high probability, would be meaningful in the clinical setting.
Thus far, the relationship between CAC and left ventricular (LV) hypertrophy has not been documented. We identified factors
associated with a CAC score of zero and evaluated the relationship between this score and LV concentric hypertrophy in 309
consecutive patients with suspected CAD who were clinically indicated to undergo multislice computed tomography angiography
for coronary artery evaluation. The quantitative CAC score was calculated according to Agatston’s method. The total coronary
calcium score (TCS) was defined as the sum of the scores for each lesion. Four absolute TCS categories were considered: zero,
mild (0–100), moderate (100–400), and severe (>400). LV hypertrophy was classified into concentric (LV mass index >104 g/m2 in women or >116 g/m2 in men; LV end-diastolic volume index ≤109.2 mL/m2) and eccentric (LV end-diastolic volume index >109.2 mL/m2) patterns. In the zero-TCS group, the frequency of LV concentric hypertrophy was extremely low (zero 6%, mild 17%, moderate
26%, severe 19%). Multivariate analysis revealed that age, hypercholesterolemia, diabetes mellitus, LV concentric hypertrophy,
and LV mass index, but not hypertension, were the independent factors associated with a CAC score of zero. The present study
demonstrated that the absence of LV concentric hypertrophy was a prerequisite for a CAC score of zero. That is, the presence
of LV concentric hypertrophy, which indicated more severe underlying hypertension, long duration, or poor control of blood
pressure, implicates the presence of CAC. 相似文献
59.
60.
Ito M Yamashita Y Miyata Y Ohara M Tsutani Y Ikeda T Misumi K Harada H Omori K 《Lung cancer (Amsterdam, Netherlands)》2012,76(1):93-97
The status of mediastinal lymph node metastasis is one of the main factors determining the treatment strategy for non-small cell lung cancer (NSCLC), but the primary tumor location is not considered crucial in the tumor-node-metastasis (TMN) classification at present. The aim of this study was to estimate the prognostic value of the primary tumor location on the basis of the hilar structures in NSCLC with mediastinal lymph node metastasis. We retrospectively reviewed the cases of 337 consecutive patients who underwent surgical resection for NSCLC between 1995 and 2004, divided the pN2 NSCLC cases (n=40) into central- and peripheral-type tumors according to the distance of the primary tumor from the first branch of the extrapulmonary bronchus, and compared the surgical outcomes between these tumor groups. Eighteen and twenty-two cases were classified as central- and peripheral-type tumors, respectively. The 5-year survival rate was significantly better for patients with central-type tumors than peripheral-type tumors (51.5% vs. 21.2%, P=0.034). The location-specific prognostic tendency was noted irrespective of the presence (n=13) or absence of skip metastasis. In a multivariate Cox analysis of the N2 NSCLC cases, the primary tumor location was a significant (P=0.026) prognostic factor for overall survival. In conclusion, evaluation of the primary tumor location based on the hilar structures is useful to predict the prognosis in N2 NSCLC. 相似文献